Acar Banu, Torun Isil M, Acar Suphi
Bati Goz Hospital, Istanbul, Turkey.
Igdir State Hospital, Ophthalmology Clinic, Merkez, Igdir, Turkey.
Open Ophthalmol J. 2018 Jun 14;12:94-103. doi: 10.2174/1874364101812010094. eCollection 2018.
Advancements in cataract surgery have necessitated the availability of intraocular lens preloaded delivery systems that can safely, effectively and predictably deliver IOLs in the eye. Preloaded delivery systems simplify and reduce procedural variability during surgery preparation.
The objective of this study was to evaluate clinical acceptability, delivery characteristics and clinical outcomes in patients implanted with new generation hydrophobic acrylic Intraocular Lens with Preloaded delivery system.
This was a single centre retrospective study. Total 41 patients were enrolled in the study to get at least 38 patients for evaluation. All patients were assessed on day1 and 1, 3 and 6 months after surgery.
EYECRYL-SERT showed 'excellent' ease of insertion and handling in all 41(100%) patients. Corrected Distance Visual Acuity (CDVA) improved from 0.74±0.58 logMAR during screening to 0.03±0.04 logMAR 6 months after surgery. The Corrected Intermediate Visual Acuity (CIVA) and Corrected Near Visual Acuity (CNVA) were 0.10±0.04 and 0.01±0.02 logMAR post 6 months surgery, respectively. The refractive spherical equivalence was -1.94±2.51 D during screening, which improved significantly (p=0.0018) to -0.21±0.47 D post 6 months surgery. The low and high contrast sensitivity was 0.06±0.06 and -0.05±0.06 logMAR after 6 months surgery, respectively. The endothelial cell loss was 5.67%, 7.22% and 9.75% at 1, 3, and 6 months after surgery, respectively, as compared to screening. None of the subjects reported any adverse event during the study period.
The IOL delivery system (EYECRYL_SERT) provided desired delivery characteristics during cataract surgery and was effective in improving clinical outcomes in cataract patients.
白内障手术的进展使得眼内晶状体预装载输送系统成为必需,该系统能够安全、有效且可预测地将人工晶状体植入眼内。预装载输送系统简化并减少了手术准备过程中的操作变异性。
本研究的目的是评估使用新一代带预装载输送系统的疏水丙烯酸人工晶状体植入患者的临床可接受性、输送特性和临床结果。
这是一项单中心回顾性研究。共纳入41例患者,至少38例患者可供评估。所有患者在术后第1天以及术后1、3和6个月进行评估。
EYECRYL-SERT在所有41例(100%)患者中均显示出“极佳”的插入和操作便利性。矫正远视力(CDVA)从筛查时平均0.74±0.58 logMAR提高到术后6个月时的0.03±0.04 logMAR。术后6个月时,矫正中视力(CIVA)和矫正近视力(CNVA)分别为0.10±0.04和0.01±0.02 logMAR。筛查时屈光球镜等效度为-1.94±2.51 D,术后6个月时显著改善(p = 0.0018)至-0.21±0.47 D。术后6个月时,低对比度和高对比度敏感度分别为0.06±0.06和-0.05±0.06 logMAR。与筛查时相比,术后1、3和6个月时内皮细胞丢失率分别为5.67%、7.22%和9.75%。在研究期间,没有受试者报告任何不良事件。
人工晶状体输送系统(EYECRYL_SERT)在白内障手术期间提供了所需的输送特性,并且在改善白内障患者的临床结果方面是有效的。